BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9438415)

  • 1. Restoration of TNF-alpha-induced ceramide generation and apoptosis in resistant human leukemia KG1a cells by the P-glycoprotein blocker PSC833.
    Bezombes C; Maestre N; Laurent G; Levade T; Bettaïeb A; Jaffrézou JP
    FASEB J; 1998 Jan; 12(1):101-9. PubMed ID: 9438415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposite effects of tumor necrosis factor alpha on the sphingomyelin-ceramide pathway in two myeloid leukemia cell lines: role of transverse sphingomyelin distribution in the plasma membrane.
    Bettaieb A; Record M; Côme MG; Bras AC; Chap H; Laurent G; Jaffrézou JP
    Blood; 1996 Aug; 88(4):1465-72. PubMed ID: 8695867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [TNF-induced apoptosis and necrosis in myeloleukemia cells HL-60 is regulated by reactive oxygen metabolites depending on a cell cycle phase].
    Martynova EA; Poddubskaia EV; Polosukhina EP; Klimova SV
    Biomed Khim; 2003; 49(1):35-45. PubMed ID: 14569872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synovial fibroblasts and the sphingomyelinase pathway: sphingomyelin turnover and ceramide generation are not signaling mechanisms for the actions of tumor necrosis factor-alpha.
    Gerritsen ME; Shen CP; Perry CA
    Am J Pathol; 1998 Feb; 152(2):505-12. PubMed ID: 9466577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of the daunorubicin-triggered sphingomyelin-ceramide pathway and apoptosis in MDR cells: influence of drug transport abnormalities.
    Côme MG; Bettaieb A; Skladanowski A; Larsen AK; Laurent G
    Int J Cancer; 1999 May; 81(4):580-7. PubMed ID: 10225448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor kappa B translocation in intact HL-60 cells.
    Yang Z; Costanzo M; Golde DW; Kolesnick RN
    J Biol Chem; 1993 Sep; 268(27):20520-3. PubMed ID: 8376408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acidic sphingomyelinase-generated ceramide is needed but not sufficient for TNF-induced apoptosis and nuclear factor-kappa B activation.
    Higuchi M; Singh S; Jaffrezou JP; Aggarwal BB
    J Immunol; 1996 Jul; 157(1):297-304. PubMed ID: 8683130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis.
    Haimovitz-Friedman A; Kan CC; Ehleiter D; Persaud RS; McLoughlin M; Fuks Z; Kolesnick RN
    J Exp Med; 1994 Aug; 180(2):525-35. PubMed ID: 8046331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway.
    Pallis M; Russell N
    Blood; 2000 May; 95(9):2897-904. PubMed ID: 10779437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine protease inhibitors block neutral sphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin.
    Mansat V; Bettaïeb A; Levade T; Laurent G; Jaffrézou JP
    FASEB J; 1997 Jul; 11(8):695-702. PubMed ID: 9240970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct effects of ceramide-generating pathways in prostate adenocarcinoma cells.
    Condorelli F; Canonico PL; Sortino MA
    Br J Pharmacol; 1999 May; 127(1):75-84. PubMed ID: 10369458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor cell resistance to apoptosis due to a defect in the activation of sphingomyelinase and the 24 kDa apoptotic protease (AP24).
    Wright SC; Zheng H; Zhong J
    FASEB J; 1996 Feb; 10(2):325-32. PubMed ID: 8641566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-alpha increases ceramide without inducing apoptosis in alveolar type II epithelial cells.
    Mallampalli RK; Peterson EJ; Carter AB; Salome RG; Mathur SN; Koretzky GA
    Am J Physiol; 1999 Mar; 276(3):L481-90. PubMed ID: 10070113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-glycoprotein in acute myeloid leukaemia: therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype.
    Pallis M; Turzanski J; Higashi Y; Russell N
    Leuk Lymphoma; 2002 Jun; 43(6):1221-8. PubMed ID: 12152989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acyl chain length-specific ceramide-induced changes in intracellular Ca2+ concentration and progesterone production are not regulated by tumor necrosis factor alpha in hen granulosa cells.
    Soboloff J; Sorisky A; Désilets M; Tsang BK
    Biol Reprod; 1999 Feb; 60(2):262-71. PubMed ID: 9915989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference of HIV-1 Nef in the sphingomyelin transduction pathway activated by tumour necrosis factor-alpha in human glial cells.
    Richard A; Robichaud G; Lapointe R; Bourgoin S; Darveau A; Poulin L
    AIDS; 1997 Jan; 11(1):F1-7. PubMed ID: 9110068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of tumor necrosis factor alpha and sphingomyelin cycle activation in the induction of apoptosis by ischemia/reperfusion of the liver.
    Alessenko AV; Galperin EI; Dudnik LB; Korobko VG; Mochalova ES; Platonova LV; Shingarova LN; Shono NI; Shupik MA
    Biochemistry (Mosc); 2002 Dec; 67(12):1347-55. PubMed ID: 12600263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-beta peptide enhances tumor necrosis factor-alpha-induced iNOS through neutral sphingomyelinase/ceramide pathway in oligodendrocytes.
    Zeng C; Lee JT; Chen H; Chen S; Hsu CY; Xu J
    J Neurochem; 2005 Aug; 94(3):703-12. PubMed ID: 16033420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor-alpha activates the sphingomyelin signal transduction pathway in a cell-free system.
    Dressler KA; Mathias S; Kolesnick RN
    Science; 1992 Mar; 255(5052):1715-8. PubMed ID: 1313189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of FAN in TNF-induced apoptosis.
    Ségui B; Cuvillier O; Adam-Klages S; Garcia V; Malagarie-Cazenave S; Lévêque S; Caspar-Bauguil S; Coudert J; Salvayre R; Krönke M; Levade T
    J Clin Invest; 2001 Jul; 108(1):143-51. PubMed ID: 11435466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.